HighTower Advisors’s Merck MRK Stock Holding History

HighTower Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-234	Closed	-$3.98K	–	3767
2023 Q3	$3.98K	Buy	+234	New	+$25.2K	﹤0.01%	3439
2022 Q4	–	Sell	-1	Closed	-$1K	–	3445
2022 Q3	$1K	Buy	+1	New	+$89	﹤0.01%	3122
2022 Q1	–	Sell	-1	Closed	-$4K	–	3574
2021 Q4	$4K	Sell	1 -99	-99%	-$7.88K	﹤0.01%	3206
2021 Q3	$1K	Buy	+100	New	+$7.61K	﹤0.01%	3136

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HighTower Advisors's MRK Position: Q1 2026 in Review

HighTower Advisors reduced its Merck (MRK) stake by 4.8% in Q1 2026, selling an estimated $21.1M and leaving 3,635,404 shares worth $437M. The position accounts for 0.46% of the portfolio, ranked #33.

HighTower Advisors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

HighTower Advisors held 3,635,404 shares of Merck worth $437M as of Q1 2026.
HighTower Advisors sold 182,731 Merck shares in Q1 2026, an estimated $21.1M.
Merck made up 0.46% of HighTower Advisors's portfolio in Q1 2026, its #33 holding.
HighTower Advisors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.